Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT

Clinical trial NCT07037680 · RECRUITING

Trial details

NCT number: NCT07037680
Sponsor: JIANYANG WANG
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Non-Small Cell Lung Cancer Thoracic Radiotherapy Safety

Start date: 2024-01-01
Primary completion: 2026-01-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.